Are you diagnosed with Parkinsonʼs disease and unsure if your current medication regimen is truly optimized? The Levodopa Challenge Test (LCT) helps you assess how well you respond to medicationsl ike syndopa or levodopa and whether youʼre experiencing complications such as drug resistance—something that affects nearly 10% of patients within five years of diagnosis. The test begins after a12-hour medication break (OFF phase), during which we evaluate your condition using standardized tools like the Unified Parkinsonʼs Disease Rating Scale (UPDRS) and Dyskinesia Rating Scale. ThisOFF-phase evaluation shows your baseline functional status. After that, a ‘supradoseʼ of levodopa isprovided followed by a 1-hour rest period. Then comes the ON phase evaluation, where we assessyour improved movement and look for dyskinesias.

Patients who have undergone LCT receive improved medication regimens or are guided toward advanced surgical or neurorehabilitation options that significantly enhance their quality of life.

The LCT is your chance to personalize your treatment and take control of your Parkinsonʼs journey.

The sooner you catch, the longer your live!